Literature DB >> 17586457

A corporate workplace model for ergonomic assessments and improvements.

Linda Törnström1, Joakim Amprazis, Marita Christmansson, Jörgen Eklund.   

Abstract

Several companies have developed their own company-specific models for ergonomic improvements. This study aims to describe and identify factors supporting and hindering the implementation and application of one such corporate model for ergonomic assessment and improvement. The model has been developed by Volvo Car Corporation and implemented at an assembly plant in Göteborg, Sweden. The model is unique as it is intended to be used by production engineers and safety representatives in cooperation. The process for assessment of musculoskeletal risks is standardised and participatory, which also supports identification of solutions. Interviews, questionnaires, observation and document studies were used to evaluate the use of the model. The model was found to improve participation and collaboration among stakeholders; provide a more effective ergonomic improvement process; visually represent the ergonomics situation in the company; and give legitimacy to and awareness of ergonomics. However, the model was found to be rather resource demanding and dependent on support from management and unions. In particular, a substantial training programme and regular use of the model are needed.

Mesh:

Year:  2007        PMID: 17586457     DOI: 10.1016/j.apergo.2007.05.006

Source DB:  PubMed          Journal:  Appl Ergon        ISSN: 0003-6870            Impact factor:   3.661


  2 in total

1.  Evaluation of ergonomic physical risk factors in a truck manufacturing plant: case study in SCANIA Production Angers.

Authors:  Mohsen Zare; Agnes Malinge-Oudenot; Robert Höglund; Sophie Biau; Yves Roquelaure
Journal:  Ind Health       Date:  2015-09-30       Impact factor: 2.179

2.  Effects of participatory ergonomic intervention on the development of upper extremity musculoskeletal disorders and disability in office employees using a computer.

Authors:  Hakan Baydur; Alp Ergör; Yücel Demiral; Elif Akalın
Journal:  J Occup Health       Date:  2016-04-22       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.